Delivery Order SPE2DB22D3501-SPE2DB25FTG61
Award Date
10/25/24
Potential Completion Date
10/28/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,867.35 firm fixed-price delivery order is for the supply of Nateglinide 120 mg tablets, with a completion date of August 8, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,842.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,875,756 units of the medication Nateglinide 60 mg Tablet in 100-count packages. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 11, 2025. It is not designated as a set-aside contract,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nateglinide 60 mg tablets. The contract has a ceiling value of $4,166.99 and runs through April 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.90 delivery order contract is for the supply of Nateglinide 120 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of October 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,181.48 firm-fixed-price delivery order is for the supply of 4,568,061,670 units of the prescription medication Nateglinide 120 mg tablets. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,378.49 Firm Fixed Price Delivery Order contract provides 4,566,554,740 units of the medication Nateglinide 60 mg Tablets. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,023.68 firm fixed price delivery order covers the supply of 4,557,680,329 units of the medication Nateglinide 60 mg Tablet, with a completion date of June 30, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,444.50 firm fixed price delivery order is for the provision of 4,564,118,866 units of the pharmaceutical drug Nateglinide 120 mg tablets. The contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp's Corporate Office division located in...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,062.00 order is for the delivery of 4,563,219,779 units of the pharmaceutical product Nateglinide 120 mg Tablet UD 30s. The contract has a completion date of January 4, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp has a history of providing...
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FUA80, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,227,423 units of the pharmaceutical drug Nateglinide 60 mg Tablet in 100-count packages. The contract has a firm fixed price of $2,058.48 and a completion date of January 4, 2024. This award is not associated with any set-aside designation, indicating full and open...